Company / R&D per Share
Zimmer Biomet R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.19
FY2025
5-year range
$1.96 / $2.19
FY2021-FY2025
Trend
+5.1%
vs FY2024
Sector context
#42 of 108
Health Care
What the data says
At $2.19, Zimmer Biomet's r&d per share ranks #42 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $1.09 in FY2016 to $2.19 in FY2025.
Based on SEC 10-K filings.
2.19 in FY2025 with a 5-year CAGR of +6.6%.
Remained stable around $2.19 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Sector benchmark
#42 of 108 in Health CareTop 39% of 108This company $2.19 Sector average $2.07
▼
+5.6% above sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 5.1% year-over-year.
- Ranks #42 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.19 | +5.1% |
| FY2024 | $2.08 | -4.6% |
| FY2023 | $2.18 | +11.2% |
| FY2022 | $1.96 | -7.0% |
| FY2021 | $2.11 | +32.9% |
| FY2020 | $1.59 | -12.6% |
| FY2019 | $1.82 | +0.5% |
| FY2018 | $1.81 | -7.3% |
| FY2017 | $1.95 | +78.6% |
| FY2016 | $1.09 | -30.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026